- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JTC: [(~{E})-2-[2-[(4-oxidanylidene-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)sulfanyl]-5-[2,3,4,5,6-pentakis(fluoranyl)phenoxy]phenyl]ethenyl]phosphonic acid(Non-covalent)
- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 4 residues within 4Å:- Chain A: L.42, T.43, Q.44, A.45
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.44, A:A.45
GOL.3: 8 residues within 4Å:- Chain A: L.93, W.94, G.143, Q.144, N.145, P.146, R.148
- Ligands: SO4.13
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:L.93, A:W.94, A:G.143, A:R.148
- Water bridges: A:Q.144
GOL.17: 7 residues within 4Å:- Chain C: L.93, W.94, G.143, Q.144, N.145, R.148
- Ligands: SO4.19
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:L.93, C:W.94, C:N.145, C:R.148
- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 4 residues within 4Å:- Chain A: R.133, R.168, R.171
- Chain C: Y.249
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: P.57, R.58, K.95
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: R.173, P.283, L.284
Ligand excluded by PLIPSO4.7: 1 residues within 4Å:- Chain A: R.168
Ligand excluded by PLIPSO4.8: 6 residues within 4Å:- Chain A: G.32, S.33, G.34, L.35, G.36
- Ligands: JTC.1
Ligand excluded by PLIPSO4.9: 3 residues within 4Å:- Chain A: P.54, N.55, F.56
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: R.207, Y.249
- Chain B: R.133
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain A: P.92, Q.144
- Chain B: R.148
- Ligands: GOL.3
Ligand excluded by PLIPSO4.14: 10 residues within 4Å:- Chain A: L.138, F.141, S.142
- Chain B: L.138, F.141, S.142
- Chain C: L.138, F.141, S.142
- Ligands: NA.11
Ligand excluded by PLIPSO4.15: 5 residues within 4Å:- Chain B: S.33, G.34, L.35, G.36
- Ligands: JTC.12
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain B: P.92, Q.144
- Chain C: R.148
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain A: R.148
- Chain C: P.92, Q.144
- Ligands: GOL.17
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain C: I.53, P.54, N.55, F.56
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain C: R.173, P.283, L.284
- Ligands: NA.26
Ligand excluded by PLIPSO4.22: 5 residues within 4Å:- Chain B: Y.249
- Chain C: R.133, R.168, R.171, E.189
Ligand excluded by PLIPSO4.23: 4 residues within 4Å:- Chain C: T.6, Y.7, E.8, R.154
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain A: R.133
- Chain C: R.207, Y.249
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain B: R.207, Y.249
- Chain C: R.133
Ligand excluded by PLIP- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skacel, J. et al., Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-05-17
- Peptides
- Purine nucleoside phosphorylase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JTC: [(~{E})-2-[2-[(4-oxidanylidene-3,5-dihydropyrrolo[3,2-d]pyrimidin-7-yl)sulfanyl]-5-[2,3,4,5,6-pentakis(fluoranyl)phenoxy]phenyl]ethenyl]phosphonic acid(Non-covalent)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skacel, J. et al., Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. J.Med.Chem. (2023)
- Release Date
- 2023-05-17
- Peptides
- Purine nucleoside phosphorylase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C